Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer

Lung Cancer

Volumn 92, Issue , 2016, Pages 47-52

  Tsurugai, Yuichiro ^a   Kozuka, Takuyo ^a   Ishizuka, Naoki ^a   Oguchi, Masahiko ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Consolidation tumor ratio; Ground glass opacity; Non small cell lung cancer; Stereotactic body radiotherapy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREATHING FREQUENCY MONITOR; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPRESSION PLATE; COMPUTER ASSISTED TOMOGRAPHY; CONSOLIDATION TUMOR RATIO; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FATALITY; FEMALE; FOLLOW UP; HUMAN; IMAGING SOFTWARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTILEAF COLLIMATOR; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REGIONAL METASTASIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; STEREOTACTIC BODY FRAME; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC DEVICE; SURVIVAL RATE; TREATMENT DURATION; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; PATHOLOGY; RADIOSURGERY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RADIOSURGERY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84978715629     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.12.003     Document Type: Article

References (17)

1. [1] Inoue, T., Shimizu, S., Onimaru, R., Takeda, A., Onishi, H., Nagata, Y., Kimura, T., Karasawa, K., Arimoto, T., Hareyama, M., Kikuchi, E., Shirato, H., Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. Int. J. Radiat. Oncol. Biol. Phys. 75 (2009), 683–687.
2. [2] Onishi, H., Araki, T., Shirato, H., Nagata, Y., Hiraoka, M., Gomi, K., Yamashita, T., Niibe, Y., Karasawa, K., Hayakawa, K., Takai, Y., Kimura, T., Hirokawa, Y., Takeda, A., Ouchi, A., Hareyama, M., Kokubo, M., Hara, R., Itami, J., Yamada, K., Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004), 1623–1631.
3. [3] Lagerwaard, F.J., Verstegen, N.E., Haasbeek, C.J., Slotman, B.J., Paul, M.A., Smit, E.F., Senan, S., Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 83 (2012), 348–353.
4. [4] Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., Gomi, K., Karasawa, K., Hayakawa, K., Niibe, Y., Takai, Y., Kimura, T., Takeda, A., Ouchi, A., Hareyama, M., Kokubo, M., Kozuka, T., Arimoto, T., Hara, R., Itami, J., Araki, T., Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery. Int. J. Radiat. Oncol. Biol. Phys. 81 (2011), 1352–1358.
5. [5] Suzuki, K., Koike, T., Asakawa, T., Kusumoto, M., Asamura, H., Nagai, K., Tada, H., Mitsudomi, T., Tsuboi, M., Shibata, T., Fukuda, H., Kato, H., A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J. Thorac. Oncol. 6 (2011), 751–756.
6. [6] Asamura, H., Hishida, T., Suzuki, K., Koike, T., Nakamura, K., Kusumoto, M., Nagai, K., Tada, H., Mitsudomi, T., Tsuboi, M., Shibata, T., Fukuda, H., Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J. Thorac. Cardiovasc. Surg. 146 (2013), 24–30.
7. [7] Nakamura, K., Saji, H., Nakajima, R., Okada, M., Asamura, H., Shibata, T., Nakamura, S., Tada, H., Tsuboi, M., A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn. J. Clin. Oncol. 40 (2010), 271–274.
8. [8] Yanagawa, N., Shiono, S., Abiko, M., Ogata, S.Y., Sato, T., Tamura, G., The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma. Ann. Thorac. Surg. 98 (2014), 453–458.
9. [9] Badiyan, S.N., Bierhals, A.J., Olsen, J.R., Creach, K.M., Garsa, A.A., Dewees, T., Bradley, J.D., Robinson, C.G., Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. Radiat. Oncol., 8, 2013, 4 8.
10. [10] Onishi, H., Shioyama, Y., Matsumoto, Y., Shibamoto, Y., Miyakawa, A., Suzuki, G., Sasaki, R., Miyawaki, D., Nishimura, Y., Ryusuke, R., Stereotactic body radiation therapy in 95 patients with lung tumors composed of ground–glass opacity (GGO): results of a retrospective multicenter study. Int. J. Radiat. Oncol. Biol. Phys., 84, 2012, S49.
11. [11] Uehara, H., Tsutani, Y., Okumura, S., Nakayama, H., Adachi, S., Yoshimura, M., Miyata, Y., Okada, M., Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma. Ann. Thorac. Surg. 96 (2013), 1958–1965.
12. [12] Kishimoto, M., Iwano, S., Ito, S., Kato, K., Ito, R., Naganawa, S., Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT. Lung Cancer 86 (2014), 180–184.
13. [13] Koike, T., Yamato, Y., Yoshiya, K., Toyabe, S., Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J. Thorac. Oncol. 7 (2012), 1246–1251.
14. [14] Koike, T., Tsuchiya, R., Goya, T., Sohara, Y., Miyaoka, E., Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan. J. Thorac. Oncol. 2 (2007), 408–413.
15. [15] Travis, W.D., Brambilla, E., Noguchi, M., Nicholson, A.G., Geisinger, K.R., Yatabe, Y., Beer, D.G., Powell, C.A., Riely, G.J., Van Schil, P.E., Garg, K., Austin, J.H., Asamura, H., Rusch, V.W., Hirsch, F.R., Scagliotti, G., Mitsudomi, T., Huber, R.M., Ishikawa, Y., Jett, J., Sanchez-Cespedes, M., Sculier, J.P., Takahashi, T., Tsuboi, M., Vansteenkiste, J., Wistuba, I., Yang, P.C., Aberle, D., Brambilla, C., Flieder, D., Franklin, W., Gazdar, A., Gould, M., Hasleton, P., Henderson, D., Johnson, B., Johnson, D., Kerr, K., Kuriyama, K., Lee, J.S., Miller, V.A., Petersen, I., Roggli, V., Rosell, R., Saijo, N., Thunnissen, E., Tsao, M., Yankelewitz, D., International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 6 (2011), 244–285.
16. [16] Takahashi, M., Shigematsu, Y., Ohta, M., Tokumasu, H., Matsukura, T., Hirai, T., Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters. J. Thorac. Cardiovasc. Surg. 147 (2014), 54–59.
17. [17] Tsuta, K., Kawago, M., Inoue, E., Yoshida, A., Takahashi, F., Sakurai, H., Watanabe, S., Takeuchi, M., Furuta, K., Asamura, H., Tsuda, H., The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 81 (2013), 371–376.